Open AccessA novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer
Author(s) -
Altiok
Publication year - 2009
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo_00000471
Subject(s) - gefitinib , epidermal growth factor receptor , cancer research , in vivo , biology , mapk/erk pathway , ex vivo , cancer , medicine , pharmacology , kinase , microbiology and biotechnology